2020 ASCO Virtual Direct™ Highlights


 

Adjuvant Therapy in Resectable NSCLC: What Does ADAURA Data Suggest on Osimertinib in EGFR+ Disease?

170 views
August 24, 2020
Comments 0
Login to view comments. Click here to Login